Effects of High- or Moderate-intensity Rosuvastatin on 1-year Major Adverse Cardiovascular Events Post-percutaneous Coronary Intervention
Effects of High- or Moderate-intensity Rosuvastatin on 1-year Major Adverse Cardiovascular Events Post-percutaneous Coronary Intervention
Atherosclerosis is the basis of adverse cardiovascular events. It has been shown that endothelial damage and inflammation play critical roles in the development and progression of atherosclerosis. Endothelial dysfunction refers to an impairment of the ability of the endothelium to properly maintain vascul...
Source: Radcliffe Cardiology - Category: Cardiology Authors: c242508f1d9059bc0f2aa9bdd5421ba2 Source Type: research
More News: Angioplasty | Cardiology | Cardiovascular | Coronary Angioplasty | Crestor | Heart | Percutaneous Coronary Intervention | Rosuvastatin